
Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns. People with diabetes prescribed semaglutide (Ozempic, Wegovy) were more than four times more likely to be diagnosed with NAION, researchers reported July 3 in the journal JAMA Ophthalmology. Further, those who were overweight were more… read on > read on >